Catalyst Compounds GLP-3

Description

Retatrutide is a synthetic peptide research compound characterized as a triple agonist acting at the GIP, GLP-1, and glucagon receptors. It is used to study convergent incretin and glucagon signaling.

Research has examined glucose regulation, energy expenditure, lipid handling, and multi-receptor signaling integration in cell cultures and rodent models. Its triple-receptor activity supports comparative study of combined metabolic pathways.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.